ArticleCancer & metabolism2023

Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combination with standard chemotherapy for patients with advanced, inoperable pancreatic adenocarcinoma: a phase 1b observational study.

Lauren K Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.